ANDA 40684, held by Taro. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 40684 (Extended Phenytoin Sodium), held by Taro, was first approved by FDA on Sep 5, 2006, with 14 approved supplements and 0 published complete response letters.
Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 5, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Extended Phenytoin Sodium100MG EXTENDED · capsule;oral | Phenytoin Sodium | Rx |
| Jul 16, 2024 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jul 16, 2024 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jan 18, 2014 | Supplement 5Labeling | Approved | None posted |
| Jan 18, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Dec 15, 2009 | Supplement 3Labeling | Approved | None posted |
| Sep 5, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters